<DOC DOCNO="nw/wsj/00/wsj_0081@0081@wsj@nw@en@on">
A licensing company representing <ENAMEX TYPE="ORG">the University of Pennsylvania</ENAMEX> added <ENAMEX TYPE="ORG">Johnson -AMP- Johnson</ENAMEX> to its lawsuit challenging a university faculty member over rights to Retin - A acne medicine .
<ENAMEX TYPE="ORG">University Patents Inc.</ENAMEX> , based in <ENAMEX TYPE="GPE">Westport</ENAMEX> , <ENAMEX TYPE="GPE">Conn.</ENAMEX> , said it seeks <ENAMEX TYPE="ORG">Johnson -AMP- Johnson 's</ENAMEX> profits from sales of Retin - A , estimated at <ENAMEX TYPE="MONEY">$ 50 million</ENAMEX> , a similar amount of punitive damages and the right to license Retin - A elsewhere .
In <ENAMEX TYPE="DATE">May</ENAMEX> , <ENAMEX TYPE="ORG">University Patents</ENAMEX> filed a suit in federal court in <ENAMEX TYPE="GPE">Philadelphia</ENAMEX> against <ENAMEX TYPE="PERSON">Albert M. Kligman</ENAMEX> , a researcher and professor at <ENAMEX TYPE="ORG">the University of Pennsylvania School of Medicine</ENAMEX> who developed Retin - A in the <ENAMEX TYPE="DATE">1960s</ENAMEX> to combat acne .
Dr. <ENAMEX TYPE="PERSON">Kligman</ENAMEX> patented the medicine while employed by the <ENAMEX TYPE="ORG">University</ENAMEX> , but later licensed the Retin - A to a division of <ENAMEX TYPE="ORG">Johnson -AMP- Johnson</ENAMEX> .
In <ENAMEX TYPE="GPE">New Brunswick</ENAMEX> , <ENAMEX TYPE="GPE">N.J.</ENAMEX> , a <ENAMEX TYPE="ORG">Johnson -AMP- Johnson</ENAMEX> spokesman declined comment .
</DOC>
